This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Fetal blood loss
P16_FETAL_BLOOD_LOSS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
21 |
4. Check minimum number of eventsNone |
21 |
5. Include endpointsNone |
21 |
6. Filter based on genotype QC (FinnGen only) |
21 |
Control definitions (FinnGen only)
- Control exclude
- P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P[5-6]
- Name in latin
- Haemorrhagia fetalis
Similar endpoints
↥List of similar endpoints to
Fetal blood loss
based on the number of shared cases.
Similar with more cases:
- Haemorrhagic and haematological disorders of fetus and newborn
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1015 | 518 | 496 |
| Only index persons | 522 | 260 | 262 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 0.04 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21 | 13 | 8 |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
6
21
3.57
1.64
13.2
12.8
mmol/l
5.8
4.2
—
6
21
(3026782) Osmolality of Urine
6
24
3.08
1.42
7.0
3.2
mosm/kgh2o
622.5
638.9
—
6
19
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5
18
3.31
1.37
1.8
2.6
—
7.8
—
0
9
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7
32
2.77
1.22
3.9
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
5
22
2.66
1.10
6.6
4.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
6
28
2.59
1.01
9.8
2.3
e6/l
8.0
9.2
—
6
23
(1761868) Lipid panel - Serum or Plasma
6
28
2.59
1.01
2.3
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
8
44
2.31
1.01
2.4
2.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
6
30
2.39
0.96
1.5
10.0
s
37.7
30.5
—
6
30
(3013115) Eosinophils [#/volume] in Blood
14
101
2.15
0.94
10.2
10.1
e9/l
0.2
0.2
0.39
14
83
(3041096) Erythrocytes [Presence] in Urine by Automated
6
32
2.22
0.90
4.7
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
7
40
2.12
0.82
5.6
3.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
5
88
0.43
0.80
1.6
1.5
—
0.4
—
0
13
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
9
58
1.96
0.69
7.1
4.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
9
59
1.91
0.68
4.9
3.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
6
34
2.06
0.66
4.8
4.2
—
—
—
0
0
(3012544) pH of Venous blood
6
37
1.86
0.62
2.2
11.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
6
37
1.86
0.62
2.2
11.3
kpa
5.8
6.0
—
6
37
(3006315) Basophils [#/volume] in Blood
13
98
1.85
0.60
10.7
9.4
e9/l
0.0
0.0
0.20
13
80
(3019198) Lymphocytes [#/volume] in Blood
13
100
1.78
0.59
11.2
9.3
e9/l
2.2
2.2
0.02
13
84
(3037467) Urinalysis macro (dipstick) panel - Urine
13
100
1.78
0.59
6.9
3.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
44
1.88
0.57
2.1
2.6
—
—
—
0
0
(3044889) 12 lead EKG panel
10
70
1.82
0.55
2.7
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7
48
1.68
0.54
4.3
3.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
7
48
1.68
0.54
6.7
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
8
59
1.57
0.49
21.6
10.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
16
180
0.54
0.48
4.5
4.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
96
0.60
0.45
1.4
2.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
5
34
1.61
0.44
2.4
11.3
kpa
5.8
5.1
—
5
34
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
12
97
1.55
0.44
4.1
2.4
mmol/l
1.1
1.1
0.03
12
90
(3001604) Monocytes [#/volume] in Blood
12
98
1.52
0.43
11.5
9.4
e9/l
0.5
0.5
0.24
12
79
(3050129) First trimester maternal screen panel - Serum or Plasma
0
17
0.00
0.42
0.0
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
0
18
0.00
0.42
0.0
1.1
—
1275.1
—
0
18
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
40
1.70
0.41
2.2
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
8
60
1.54
0.35
2.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
71
0.61
0.33
2.8
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
8
64
1.40
0.33
4.1
3.5
nmol/l
70.9
66.7
—
8
58
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
13
109
1.50
0.31
5.6
2.1
mmol/l
5.5
5.5
0.01
13
95
(3002030) Lymphocytes/100 leukocytes in Blood
12
100
1.46
0.31
11.8
8.8
%
34.5
35.4
0.09
12
95
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
6
49
1.31
0.23
3.2
3.9
mg/l
1.3
2.6
—
6
43
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
11
0.00
0.22
0.0
13.4
—
127.7
—
0
11
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
10
0.00
0.22
0.0
14.5
—
1.1
—
0
10
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
10
0.00
0.22
0.0
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
10
0.00
0.22
0.0
2.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
0
10
0.00
0.22
0.0
7.8
—
5.0
—
0
10
(3027801) Oxygen [Partial pressure] in Arterial blood
0
10
0.00
0.22
0.0
7.5
—
19.5
—
0
10
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
10
0.00
0.22
0.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.22
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3015736) pH of Urine
7
60
1.25
0.21
4.0
3.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
60
1.25
0.21
2.3
2.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
9
79
1.24
0.19
14.7
10.8
mmol/l
1.2
1.2
—
9
70
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
10
85
1.34
0.16
18.3
5.0
u/l
108.4
106.8
—
10
80
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
10
87
1.29
0.12
4.1
2.6
mmol/mol
34.7
35.3
—
10
79
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
42
1.25
0.11
13.0
12.0
mmol/l
24.0
24.7
—
5
42
(36660697) Celiac disease serology panel - Serum
5
44
1.18
0.11
1.2
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
11
98
1.26
0.10
12.5
8.7
%
2.3
2.9
0.67
11
90
(3019069) Monocytes/100 leukocytes in Blood
11
98
1.26
0.10
13.5
8.9
%
8.2
8.3
0.04
11
93
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
15
156
0.87
0.10
4.9
3.1
mu/l
2.7
1.8
1.56
15
145
(3019550) Sodium [Moles/volume] in Serum or Plasma
16
148
1.34
0.10
18.1
12.5
mmol/l
139.4
139.3
0.19
16
143
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
7
79
0.83
0.09
20.6
11.5
mmol/l
1.2
1.2
—
7
74
(42870588) Differential panel, method unspecified - Blood
8
75
1.11
0.09
10.5
10.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
9
82
1.17
0.09
14.7
7.2
mmol/l
5.9
5.9
—
9
77
(3018010) Neutrophils/100 leukocytes in Blood
11
100
1.21
0.07
13.2
8.7
%
50.5
49.8
0.06
11
94
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
11
104
1.12
0.01
3.7
2.5
mmol/l
1.3
1.4
0.45
11
94
(3013707) Erythrocyte sedimentation rate by Westergren method
11
113
0.94
0.00
5.6
4.3
mm/h
11.8
7.5
0.46
11
106
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
11
105
1.10
0.00
3.8
2.5
mmol/l
2.9
2.7
0.22
11
95
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
11
105
1.10
0.00
3.7
2.6
mmol/l
4.4
4.5
0.05
11
95
(3021589) Normoblasts [#/volume] in Blood
10
102
0.96
0.00
10.9
10.3
e9/l
0.0
0.0
—
10
77
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
7.2
—
89.6
—
0
5
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
5
0.00
0.00
0.0
10.0
—
51.0
—
0
5
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
3.4
—
181.0
—
0
5
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
5.5
—
0
5
(4268621)
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3019225) pH of Specimen
0
6
0.00
0.00
0.0
7.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
8.0
—
24.9
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
50
1.00
0.00
2.2
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
0
7
0.00
0.00
0.0
10.1
—
96.3
—
0
7
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
7
0.00
0.00
0.0
10.1
—
0.6
—
0
7
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
0
7
0.00
0.00
0.0
10.7
—
123.6
—
0
7
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.9
—
324.0
—
0
7
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
7
0.00
0.00
0.0
10.1
—
0.9
—
0
7
(3016502) Oxygen saturation in Arterial blood
0
8
0.00
0.00
0.0
9.5
—
98.0
—
0
8
(3019230) Fractional oxyhemoglobin in Venous blood
0
6
0.00
0.00
0.0
15.8
—
76.8
—
0
6
(3006598) pH of Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
9
88
1.04
0.00
4.1
3.6
ug/l
131.8
35.0
—
9
80
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
3.4
—
0
6
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
0
7
0.00
0.00
0.0
10.3
—
22.6
—
0
7
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
57
1.07
0.00
2.7
2.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
18.7
—
0
6
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
16
161
0.97
0.00
14.7
7.8
u/l
21.6
26.1
0.61
16
155
(3007566) Smooth muscle Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
7.1
—
0
6
(42870560) Thyrotropin [Units/volume] in Cord blood
0
8
0.00
0.00
0.0
1.0
—
8.1
—
0
8
(3020891) Body temperature
0
7
0.00
0.00
0.0
9.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_FETAL_BLOOD_LOSS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_FETAL_BLOOD_LOSS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_FETAL_BLOOD_LOSS – Fetal blood loss
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data